BackInnoCan Pharma Overview

InnoCan Pharma Current Assets

Track InnoCan Pharma's current assets ($9.8M) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$9.75M
↓ 10.82% YoYΔ $-1.18M vs prior year quarter

Peer trimmed avg / median

Loading

InnoCan Pharma Current Assets History

Loading

InnoCan Pharma vs. peers: Current Assets Comparison

Loading

InnoCan Pharma Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

InnoCan Pharma (INNPF) FAQ

As of the most recent data (June 2026), INNPF shows a current assets of $9.8M. That compares with $11M in the prior-year period — down 10.8% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, INNPF's current assets is now $9.8M (was $11M) — a 10.8% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether InnoCan Pharma is outperforming or lagging.

Tracking INNPF's current assets over time shows whether InnoCan Pharma is scaling, shrinking, or reshaping that part of the business. The current reading is $9.8M That compares with $11M in the prior-year period — down 10.8% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current assets page, Stockcircle has InnoCan Pharma's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current assets (currently $9.8M) with ownership activity and broader fundamentals.

Questions & Answers